Safety, Efficacy and Tolerability of Bowel Preparation and Colonoscopy in Patient With CHD, CKD and CLD

Launched by ASIAN INSTITUTE OF GASTROENTEROLOGY, INDIA · Mar 11, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the safety and effectiveness of a bowel preparation method for patients with chronic heart disease, chronic kidney disease, or chronic liver disease who need a colonoscopy. The goal is to ensure that the bowel is clean enough for the procedure while monitoring how well patients tolerate the preparation process. Eligible participants are adults over 18 years old who have been diagnosed with one of these conditions and are scheduled for an elective colonoscopy.

Participants can expect to follow a specific preparation routine that includes taking a medication called bisacodyl the night before the colonoscopy and drinking a special solution called PEG the night before and the morning of the procedure. They will be closely monitored throughout the process to assess how well they respond and tolerate the bowel preparation. The trial is currently recruiting participants, and it is important to note that individuals with certain medical conditions, like bowel obstructions or a history of specific surgeries, are not eligible to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult \>18 years
• • Diagnosed cases of chronic heart disease, chronic kidney disease or chronic liver failure planned for elective colonoscopy
• Exclusion Criteria:
• • Age \< 18 years
• • Current or past history of bowel obstruction or resection
• • Known allergies to PEG
• • Emergency colonoscopies.
• • Pregnant or lactating women
• • Paralytic ileus / Bowel perforation
• • Inability to protect airway